Victoire Ruffino-Cardot

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Digital home-based multimodal prehabilitation of colorectal cancer patients prior to surgery (the dHOPE study): a non-inferiority clinical trial protocol.

Digital home-based multimodal prehabilitation of colorectal cancer patients prior to surgery (the dHOPE study): a non-inferiority clinical trial protocol.

Journal: Frontiers in digital health

Published: April 17, 2025

Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer.

Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer.

Journal: Cancer cell

Published: April 14, 2025

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.

Journal: Cancer immunology research

Published: February 07, 2024

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma.

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma.

Journal: Journal for immunotherapy of cancer

Published: October 18, 2023

G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans.

G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans.

Journal: Journal for immunotherapy of cancer

Published: June 04, 2023

The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy.

The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy.

Journal: The lancet. Gastroenterology & hepatology

Published: May 20, 2023

PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer.

PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 16, 2023

Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy.

Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy.

Journal: Gastroenterology

Published: December 07, 2022

Physical Activity as the Best Supportive Care in Cancer: The Clinician's and the Researcher's Perspectives.

Physical Activity as the Best Supportive Care in Cancer: The Clinician's and the Researcher's Perspectives.

Journal: Cancers

Published: September 14, 2022

SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4.

SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4.

Journal: Communications biology

Published: September 03, 2021

Hypothalamic-pituitary-adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of Apc mice.

Hypothalamic-pituitary-adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of Apc mice.

Journal: Journal of cachexia, sarcopenia and muscle

Published: June 18, 2021

Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling.

Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling.

Journal: Cell death & disease

Published: January 25, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026